Clinical Report: The Impact of Astragalus membranaceus on Immune Tolerance
Overview
This review highlights the role of Astragalus membranaceus and its derivatives in restoring immune tolerance, particularly in gastrointestinal disorders. It summarizes findings from 112 studies, emphasizing the multi-target regulatory effects of these agents on immune function and gut microbiota.
Background
The gastrointestinal tract is a crucial immune organ that maintains immune tolerance to prevent autoimmune diseases and tumors. Traditional Chinese medicine, particularly Astragalus membranaceus, has gained attention for its potential to regulate immune function and restore balance in immune tolerance. Understanding these mechanisms is vital for developing effective treatments for digestive diseases linked to immune dysregulation.
Data Highlights
No numerical data or trial data provided in the source material.
Key Findings
Astragalus membranaceus (AM) exhibits efficacy in restoring immune tolerance in gastrointestinal disorders.
AM modulates core signaling pathways and immune cell function to achieve immune homeostasis.
It rebalances immune axes such as Th1/Th2 and Treg/Th17.
The review summarizes findings from 112 studies published between December 2020 and December 2025.
AM's mechanisms include multi-target and multi-pathway regulatory effects rather than isolated modulations.
Clinical Implications
The findings suggest that Astragalus membranaceus could be considered in the therapeutic framework for managing gastrointestinal disorders associated with immune tolerance issues. Further research may elucidate its potential as an adjunct therapy in clinical practice.
Conclusion
Astragalus membranaceus presents a promising avenue for restoring immune tolerance in gastrointestinal disorders, warranting further investigation into its therapeutic applications.
